Functional and profiling studies prove that prostate cancer upregulated neuroblastoma thymosin β is the true human homologue of rat thymosin β15

FEBS Letters

Volumn 581, Issue 25, 2007, Pages 4809-4815

  Dhaese, S ^a,b   Jonckheere, V ^a,b   Goethals, M ^a,b   Waltregny, D ^c   Vandekerckhove, J ^a,b   Ampe, C ^a,b   Van Troys, M ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Actin; Cancer; Cell migration; Cytoskeleton; Prostate; Thymosin

Indexed keywords

ACTIN; THYMOSIN; THYMOSIN BETA; THYMOSIN BETA 15; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; NEUROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; RAT; UPREGULATION;

ACTINS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL MOVEMENT; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; RATS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; THYMOSIN; UP-REGULATION;

RATTUS;

EID: 34948822376     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.09.003     Document Type: Article

References (25)

1. Wang W.S., Chen P.M., Hsiao H.L., Ju S.Y., and Su Y. Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 22 (2003) 3297-3306
2. Lee S.H., Son M.J., Oh S.H., Rho S.B., Park K., Kim Y.J., Park M.S., and Lee J.H. Thymosin {beta}(10) inhibits angiogenesis and tumor growth by interfering with Ras function. Cancer Res. 65 (2005) 137-148
3. Bao L., Loda M., Janmey P.A., Stewart R., Anand-Apte B., and Zetter B.R. Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat. Med. 2 (1996) 1322-1328
4. Huff T., Muller C.S., Otto A.M., Netzker R., and Hannappel E. β-Thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 33 (2001) 205-220
5. Yokoyama M., Nishi Y., Yoshii J., Okubo K., and Matsubara K. Identification and cloning of neuroblastoma-specific and nerve tissue-specific genes through compiled expression profiles. DNA Res. 3 (1996) 311-320
6. Hutchinson L.M., et al. Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer. Clin. Biochem. 38 (2005) 558-571
7. Choe J., Sun W., Yoon S.Y., Rhyu I.J., Kim E.H., and Kim H. Effect of thymosin beta15 on the branching of developing neurons. Biochem. Biophys. Res. Commun. 331 (2005) 43-49
8. Choi S.Y., Kim D.K., Eun B., Kim K., Sun W., and Kim H. Anti-apoptotic function of thymosin-beta in developing chick spinal motoneurons. Biochem. Biophys. Res. Commun. 346 (2006) 872-878
9. Koutrafouri V., Leondiadis L., Ferderigos N., Avgoustakis K., Livaniou E., Evangelatos G.P., and Ithakissios D.S. Synthesis and angiogenetic activity in the chick chorioallantoic membrane model of thymosin beta-15. Peptides 24 (2003) 107-115
10. Spudich J.A., and Watt S. The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. J. Biol. Chem. 246 (1971) 4866-4871
11. Brenner S.L., and Korn E.D. On the mechanism of actin monomer-polymer subunit exchange at steady state. J. Biol. Chem. 258 (1983) 5013-5020
12. Dassesse T., de Leval X., de Leval L., Pirotte B., Castronovo V., and Waltregny D. Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. Eur. Urol. 50 (2006) 1021-1031 discussion 1031
13. Van Troys M., Dewitte D., Goethals M., Carlier M.F., Vandekerckhove J., and Ampe C. The actin binding site of thymosin beta 4 mapped by mutational analysis. Embo J. 15 (1996) 201-210
14. Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., and Vandekerckhove J. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol. 21 (2003) 566-569
15. Schmidt M., Schler G., Gruensfelder P., and Hoppe F. Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line. Eur. Arch. Otorhinolaryngol. 263 (2006) 127-134
16. Bao L., Loda M., and Zetter B.R. Thymosin beta15 expression in tumor cell lines with varying metastatic potential. Clin. Exp. Meta. 16 (1998) 227-233
17. Otto A.M., Muller C.S., Huff T., and Hannappel E. Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells. J. Cancer Res. Clin. Oncol. 128 (2002) 247-256
18. Banyard J., Hutchinson L.M., and Zetter B.R. Thymosin {beta}-NB is the human isoform of rat thymosin {beta}15. Ann. NY Acad. Sci. (2007)
19. Safer D., Sosnick T.R., and Elzinga M. Thymosin beta 4 binds actin in an extended conformation and contacts both the barbed and pointed ends. Biochemistry 36 (1997) 5806-5816
20. Domanski M., Hertzog M., Coutant J., Gutsche-Perelroizen I., Bontems F., Carlier M.F., Guittet E., and van Heijenoort C. Coupling of folding and binding of thymosin beta4 upon interaction with monomeric actin monitored by nuclear magnetic resonance. J. Biol. Chem. 279 (2004) 23637-23645
21. Irobi E., Aguda A.H., Larsson M., Guerin C., Yin H.L., Burtnick L.D., Blanchoin L., and Robinson R.C. Structural basis of actin sequestration by thymosin-beta4: implications for WH2 proteins. Embo J. 23 (2004) 3599-3608
22. Vancompernolle K., Goethals M., Huet C., Louvard D., and Vandekerckhove J. G- to F-actin modulation by a single amino acid substitution in the actin binding site of actobindin and thymosin beta 4. Embo J. 11 (1992) 4739-4746
23. Huff T., Muller C.S., and Hannappel E. C-terminal truncation of thymosin beta10 by an intracellular protease and its influence on the interaction with G-actin studied by ultrafiltration. FEBS Lett. 414 (1997) 39-44
24. Eadie J.S., Kim S.W., Allen P.G., Hutchinson L.M., Kantor J.D., and Zetter B.R. C-terminal variations in beta-thymosin family members specify functional differences in actin-binding properties. J. Cell Biochem. 77 (2000) 277-287
25. Chakravatri A., et al. Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. Urology 55 (2000) 635-638